The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.

about

The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.

Item

http://www.wikidata.org/entity/Q40340923

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The novel oral glucan synthase ...... le and planktonic Candida spp.

@en

type

Item

label

The novel oral glucan synthase ...... le and planktonic Candida spp.

@en

prefLabel

The novel oral glucan synthase ...... le and planktonic Candida spp.

@en

P1476

The novel oral glucan synthase ...... le and planktonic Candida spp.

@en

P2093

Jesús Guinea

http://www.w3.org/2001/XMLSchema#string

Marta Gómez-Perosanz

http://www.w3.org/2001/XMLSchema#string

P2860

Echinocandin resistance: an emerging clinical problem?

Echinocandin antifungal drugs

Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.

Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model.

Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations.

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.

Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

Current perspectives on echinocandin class drugs.

P304

1969-1976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX010

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emilio Bouza

Pilar Escribano

Laura Judith Marcos-Zambrano

P577

2017-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28175309

http://www.w3.org/2001/XMLSchema#string

P921

I-phytoplankton